Radiotherapy for NSCLC: Review of conventional and new treatment techniques-Reference-Cited by-同舟云学术

Radiotherapy for NSCLC: Review of conventional and new treatment techniques

Published:2012-12 Issue: Volume:5 Page:S45-S49
ISSN:1876-0341
Container-title:Journal of Infection and Public Health
language:en
Short-container-title:Journal of Infection and Public Health

Author:

Saadeddin Ahmed

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine

Reference10 articles.

1. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy;Liao;International Journal of Radiation Oncology Biology Physics,2010

2. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy;Yom;International Journal of Radiation Oncology Biology Physics,2007

3. Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume;Brianzoni;European Journal of Nuclear Medicine and Molecular Imaging,2005

4. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer;Ashamalla;International Journal of Radiation Oncology Biology Physics,2005

5. Long term benefit is observed in a phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresectable NSCLC:RTOG 9410;Curran;Proceedings of the American Society of Clinical Oncology,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Image guided radiotherapy;2023 International Conference on Computer Graphics and Image Processing (CGIP);2023-01

2. Hype or hope – Can combination therapies with third-generation EGFR-TKIs help overcome acquired resistance and improve outcomes in EGFR-mutant advanced/metastatic NSCLC?;Critical Reviews in Oncology/Hematology;2021-10

3. Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy;Cancers;2020-06-18

4. Therapeutic effects of lenvatinib in combination with rAd‑p53 for the treatment of non‑small cell lung cancer;Oncology Letters;2018-09-11

5. FOXM1 regulates radiosensitivity of lung cancer cell partly by upregulating KIF20A;European Journal of Pharmacology;2018-08